Literature DB >> 2347476

The destructive effects of sclerosant ethanolamine oleate on mammalian vessel endothelium.

M Masaki1, K Obara, S Suzuki, K Orikasa, H Mitsuhashi, K Iwasaki, H Sakamoto, T Morito, R Kasukawa.   

Abstract

Ethanolamine oleate (EO) used widely in sclerotherapy against esophageal varices was studied for its pharmacological effect on blood coagulation and vascular damage in animals. Blood coagulation was completely inhibited by EO at a concentration of 0.31%. EO destroyed the endothelial cells of the vessel of dog and rat within one minute after injection into the vessels. An accumulation of fibrin and platelets on the surface of the damaged vessel was observed electron microscopically. Mural thrombus was formed in a few hours and the thrombus occluded the blood stream in the vein. From these animal experiment, intravasal injection of EO was considered to cause the disappearance of varices by the following two processes: collapse of varices because of occlusion of the blood stream and shrinking of the obstructed thrombus through organization.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2347476     DOI: 10.1007/bf02776821

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  12 in total

1.  Treatment of oesophageal varices in portal hypertension by means of sclerosing injections.

Authors:  R MACBETH
Journal:  Br Med J       Date:  1955-10-08

2.  Injection of sclerosing solutions in the treatment of esophageal varices.

Authors:  S G KEMPE; H KOCH
Journal:  Acta Otolaryngol Suppl       Date:  1954

3.  Treatment of oesophageal varices by injections of sclerosing agents through oesophagoscope in splenectomized patient suffering from splenic phlebostenosis (splenic anemia); a case with autopsy.

Authors:  E TROLLE; D TROLLE
Journal:  Acta Chir Scand       Date:  1946-09-10

4.  The sclerosing therapy of esophageal varices.

Authors:  C O PATTERSON; M O ROUSE
Journal:  Gastroenterology       Date:  1947-10       Impact factor: 22.682

5.  [In vitro assay of cytotoxicity of sclerosants against esophageal varices on human cultured endothelial cells].

Authors:  K Orikasa
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1986-07

6.  A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices.

Authors:  G W Johnston; H W Rodgers
Journal:  Br J Surg       Date:  1973-10       Impact factor: 6.939

7.  Comparison of tetradecyl sulphate sodium with other sclerosants in rats.

Authors:  W K Blenkinsopp
Journal:  Br J Exp Pathol       Date:  1968-04

8.  [A pathological study on endoscopical sclerotherapy for esophageal varices].

Authors:  M Arakawa; K Fukuda; T Noda; M Kage; T Nakashima; K Nagata; S Kawaguchi; T Sakisaka; S Eguchi; A Toyonaga
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1983-12

9.  A prospective evaluation of injection sclerotherapy in the treatment of acute bleeding from esophageal varices.

Authors:  J Terblanche; J M Northover; P Bornman; D Kahn; G O Barbezat; S L Sellars; S J Saunders
Journal:  Surgery       Date:  1979-03       Impact factor: 3.982

10.  Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial.

Authors:  B R MacDougall; D Westaby; A Theodossi; J L Dawson; R Williams
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

View more
  11 in total

1.  Prediction of the recurrence of esophageal varices based on portal vein pressure and oxygen tension in portal and peripheral blood.

Authors:  K Obara; H Sakamoto; R Kasukawa
Journal:  Gastroenterol Jpn       Date:  1991-12

2.  Pharmacology of sclerotherapy.

Authors:  Giustino Albanese; Kimi L Kondo
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

3.  Pulmonary embolism secondary to balloon-occluded retrograde transvenous obliteration for gastric varix.

Authors:  Satoshi Nakayama; Naoya Murashima
Journal:  Indian J Gastroenterol       Date:  2013-09

Review 4.  Balloon-occluded retrograde transvenous obliteration of varices: focusing on the portal hemodynamics and the recent techniques.

Authors:  Shozo Hirota; Kaoru Kobayashi; Yasukazu Kako; Haruyuki Takaki; Koichiro Yamakado
Journal:  Hepatol Int       Date:  2017-09-05       Impact factor: 6.047

5.  A new technique of combined endoscopic sclerotherapy and ligation for variceal bleeding.

Authors:  Radha K Dhiman; Yogesh K Chawla
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

6.  Healing process after surgical treatment with scalpel, electrocautery and laser radiation: histomorphologic and histomorphometric analysis.

Authors:  Aline Rose Cantarelli Morosolli; Elaine Bauer Veeck; Walter Niccoli-Filho; Mônica Fernandes Gomes; Maria das Graças V Goulart
Journal:  Lasers Med Sci       Date:  2009-04-30       Impact factor: 3.161

7.  Differences in hemostasis among sclerosing agents in endoscopic injection sclerotherapy.

Authors:  M Tatemichi; H Nagata; E Sekizuka; T Morishita; M Miyairi; M Tsuchiya; H Ishii
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

8.  Utility of low-dose gelatin sponge particles and 5% ethanolamine oleate iopamidol mixture in retrograde transvenous obliteration (GERTO) for gastric varices.

Authors:  Atsushi Jogo; Akira Yamamoto; Toshio Kaminoh; Mariko Nakano; Ken Kageyama; Etsuji Sohgawa; Shinichi Hamamoto; Yukimasa Sakai; Masao Hamuro; Norifumi Nishida; Yukio Miki
Journal:  Br J Radiol       Date:  2020-02-14       Impact factor: 3.039

9.  Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis.

Authors:  Keiji Yokoyama; Ryo Yamauchi; Kumiko Shibata; Hiromi Fukuda; Hideo Kunimoto; Kazuhide Takata; Takashi Tanaka; Shinjiro Inomata; Daisuke Morihara; Yasuaki Takeyama; Satoshi Shakado; Shotaro Sakisaka
Journal:  Clin Mol Hepatol       Date:  2018-11-09

10.  Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients.

Authors:  Taku Mizutani; Kazushige Nirei; Tatsuo Kanda; Masayuki Honda; Tomotaka Ishii; Shuhei Arima; Yoichiro Yamana; Naoki Matsumoto; Shunichi Matsuoka; Mitsuhiko Moriyama
Journal:  Medicina (Kaunas)       Date:  2022-01-28       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.